- The company’s sales are growing rapidly, driven by strong acquisitions, outsourcing contracts with hospitals and robust organic growth.
- The company’s EBITDA 09 estimated at 19%
- Financing: acquisitions in Slovakia are leveraged by 85% by Tatra banka a.s.
